Time to reinfection and vaccine breakthrough SARS-CoV-2 infections: a retrospective cohort study

Sevda Molani, Andrew M. Baumgartner, Yeon Mi Hwang, Venkata R. Duvvuri, Jason D. Goldman, Jennifer J. Hadlock
doi: https://doi.org/10.1101/2022.02.07.22270613

Article Information

doi 
https://doi.org/10.1101/2022.02.07.22270613
History 
  • February 8, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.

Author Information

  1. Sevda Molani1,,
  2. Andrew M. Baumgartner1,,
  3. Yeon Mi Hwang1,,
  4. Venkata R. Duvvuri, PhD, MPH1,
  5. Jason D. Goldman, MD2,3,4 and
  6. Jennifer J. Hadlock, MD1,*
  1. 1Institute for Systems Biology, Seattle, Washington, United States of America
  2. 2Swedish Center for Research and Innovation, Seattle, Washington, United States of America
  3. 3Providence St. Joseph Health, Renton, Washington, United States of America
  4. 4Division of Allergy & Infectious Diseases, University of Washington, Seattle, Washington, United States of America
  1. ↵*Corresponding author E-mail: jhadlock{at}isbscience.org

  1. ↵ These authors contributed equally to this work

Back to top
Posted February 08, 2022.
Download PDF
Data/Code
Email
Time to reinfection and vaccine breakthrough SARS-CoV-2 infections: a retrospective cohort study
Sevda Molani, Andrew M. Baumgartner, Yeon Mi Hwang, Venkata R. Duvvuri, Jason D. Goldman, Jennifer J. Hadlock
medRxiv 2022.02.07.22270613; doi: https://doi.org/10.1101/2022.02.07.22270613
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area